Antithrombotic Therapy in Myocardial Infarction: Historic Perils and Current Challenges-A 70-Year Journey.

Animals Anticoagulants / therapeutic use Aspirin / therapeutic use Humans Myocardial Infarction / complications Percutaneous Coronary Intervention / adverse effects Platelet Aggregation Inhibitors / therapeutic use Purinergic P2Y Receptor Antagonists / therapeutic use Rivaroxaban / therapeutic use Thrombosis / etiology

Journal

Thrombosis and haemostasis
ISSN: 2567-689X
Titre abrégé: Thromb Haemost
Pays: Germany
ID NLM: 7608063

Informations de publication

Date de publication:
Oct 2020
Historique:
pubmed: 25 7 2020
medline: 3 8 2021
entrez: 25 7 2020
Statut: ppublish

Résumé

There have been numerous and intriguing advancements in antithrombotic therapy for myocardial infarction since it was described in the earliest issues of

Identifiants

DOI: 10.1055/s-0040-1714212 PMID: 32707594
pubmed: 32707594
doi: 10.1055/s-0040-1714212
doi:

Substances chimiques

Anticoagulants 0
Platelet Aggregation Inhibitors 0
Purinergic P2Y Receptor Antagonists 0
Rivaroxaban 9NDF7JZ4M3
Aspirin R16CO5Y76E

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1352-1356

Subventions

Organisme : United States
ID : National Health and Medical Research Council of Australia
Pays : United States
Organisme : United States
ID : National Health and Medical Research Council of Australia
Pays : United States

Informations de copyright

Thieme. All rights reserved.

Déclaration de conflit d'intérêts

None declared.

Auteurs

Himawan Fernando (H)

Atherothrombosis and Vascular Biology Laboratory, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
Department of Medicine, Monash University, Melbourne, Victoria, Australia.
Department of Cardiology, The Alfred Hospital, Melbourne, Victoria, Australia.

James D McFadyen (JD)

Atherothrombosis and Vascular Biology Laboratory, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
Department of Medicine, Monash University, Melbourne, Victoria, Australia.
Thrombosis and Haemostasis Unit, Department of Clinical Haematology, The Alfred Hospital, Melbourne, Victoria, Australia.

Jathushan Palasubramaniam (J)

Atherothrombosis and Vascular Biology Laboratory, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
Department of Medicine, Monash University, Melbourne, Victoria, Australia.
Department of Cardiology, The Alfred Hospital, Melbourne, Victoria, Australia.

James Shaw (J)

Department of Medicine, Monash University, Melbourne, Victoria, Australia.
Department of Cardiology, The Alfred Hospital, Melbourne, Victoria, Australia.

Xiaowei Wang (X)

Atherothrombosis and Vascular Biology Laboratory, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
Department of Medicine, Monash University, Melbourne, Victoria, Australia.

Dion Stub (D)

Department of Medicine, Monash University, Melbourne, Victoria, Australia.
Department of Cardiology, The Alfred Hospital, Melbourne, Victoria, Australia.

Karlheinz Peter (K)

Atherothrombosis and Vascular Biology Laboratory, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
Department of Medicine, Monash University, Melbourne, Victoria, Australia.
Department of Cardiology, The Alfred Hospital, Melbourne, Victoria, Australia.
Department of Immunology, Monash University, Melbourne, Victoria, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Antithrombotic Therapy in Myocardial...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Agents hématologiques › Anticoagulants › Antithrombotic Therapy in Myocardial...
questionsmedicales.fr › Composés chimiques organiques › Hydrocarbures › Hydrocarbures cycliques › Hydrocarbures aromatiques › Dérivés du benzène › Phénols › Hydroxybenzoates › Salicylates › Acide acétylsalicylique › Antithrombotic Therapy in Myocardial...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Antithrombotic Therapy in Myocardial...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Nécrose › Infarctus › Infarctus du myocarde › Antithrombotic Therapy in Myocardial...
questionsmedicales.fr › Procédures de chirurgie opératoire › Interventions chirurgicales mini-invasives › Procédures endovasculaires › Intervention coronarienne percutanée › Antithrombotic Therapy in Myocardial...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Agents hématologiques › Antiagrégants plaquettaires › Antithrombotic Therapy in Myocardial...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Effets physiologiques des médicaments › Agents neuromédiateurs › Agents purinergiques › Antagonistes purinergiques › Antagonistes des récepteurs purinergiques P2 › Antagonistes des récepteurs purinergiques P2Y › Antithrombotic Therapy in Myocardial...
questionsmedicales.fr › Composés hétérocycliques › Composés hétéromonocycliques › Thiophènes › Rivaroxaban › Antithrombotic Therapy in Myocardial...
questionsmedicales.fr › Maladies cardiovasculaires › Maladies vasculaires › Embolie et thrombose › Thrombose › Antithrombotic Therapy in Myocardial...